Related content

ALPHA-INTERFERON THERAPY AND PERIPHERAL NEUROPATHY

By Mellgren Svein Ivar  

Pediatric Hematology and Oncology, Vol. 16, Iss. 6, 1999-11 ,pp. : 499-500

Informa Healthcare

Access to resources Recommend Favorite

Food and Drug Administration (FDA) Postmarket Reported Side Effects and Adverse Events Associated with Pulmonary Hypertension Therapy in Pediatric Patients

By Maxey Dawn   Ivy D.   Ogawa Michelle   Feinstein Jeffrey  

Pediatric Cardiology, Vol. 34, Iss. 7, 2013-10 ,pp. : 1628-1636

Springer Publishing Company

Access to resources Recommend Favorite

Differential response to interferon-γ therapy in a family with dominant negative partial interferon-γ receptor1 deficiency

By Smyth Anita   Jackson Paul   Lammas David   Asghar M.   Crockard Alistair   Casanova Jean-Laurent   Kumararatne Dinakantha   Edgar J.  

European Journal of Pediatrics, Vol. 165, Iss. 1, 2006-01 ,pp. : 71-72

Springer Publishing Company

Access to resources Recommend Favorite

ETOPOSIDE AS THE BASIC AND INTERFERON-α AS THE MAINTENANCE THERAPY FOR LANGERHANS CELL HISTIOCYTOSIS: A RTC

By Culić Srdana   Jakobson Äke   Culić Vida   Kuzmić Ivana   Sćukanec-Spoljar Mira   Primorac Dragan  

Pediatric Hematology and Oncology, Vol. 18, Iss. 4, 2001-06 ,pp. : 291-294

Informa Healthcare

Access to resources Recommend Favorite

PERIPHERAL NEUROPATHY DURING ALPHA-INTERFERON THERAPY IN A CHILD WITH HODGKIN'S DISEASE

By Emir Suna   Kutluk Tezer   Chan Ka Wah   Yalcin Bilgehan   Varli Kubilay   Buyukpamukcu Munevver  

Pediatric Hematology and Oncology, Vol. 16, Iss. 6, 1999-11 ,pp. : 557-560

Informa Healthcare

Access to resources Recommend Favorite